Tradestie Institutional Equity Comparison Engine

LABT vs PFSA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PFSA Overall Edge

PFSA Captures Institutional Edge (2โ€“0 Pillars ยท 7โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Profusa, Inc. Common Stock (PFSA) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, LABT trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus PFSA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, LABT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against PFSA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
LABT N/M vs PFSA N/M Fwd P/E
Growth & Margin Winner PFSA
Op Margin N/A vs 0.0% ยท YoY N/A vs +0.0%
Momentum & Technical Winner PFSA
1Y -97.2% vs +91.4% ยท 52W Pos 1% vs 1%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
LABT US Equity
LABT
Institutional Equity
$0.24
+15.03% 1D
Market Cap N/A
1M Return -49.97%
1Y Return -97.17%
Forward P/E N/M
Unified AI Score
47.5 / 100 HOLD
Tech 45.0 Fund 48.0 Flow 50.0 Mom 64.0
PFSA NASDAQ
Profusa, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$0.32
-6.4% 1D
Market Cap $2.0M
1M Return -68.29%
1Y Return +91.36%
Forward P/E N/M
Unified AI Score
48.7 / 100 HOLD
Tech 45.0 Fund 50.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: LABT -97.17% PFSA +91.36% Spread: +51.47 pp (PFSA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
LABT TTM Op. Margin: N/A PFSA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on LABT vs PFSA. Trailing 12-month operating profitability (LABT N/A vs PFSA 0.0%) and valuation multiples (LABT N/M vs PFSA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: LABT (0) vs PFSA (7)
Institutional Metric LABT PFSA Criterion Row Winner
Market Capitalization Scale N/A $2.0M Larger Scale PFSA
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A +0.0% Higher Growth PFSA
Operating Margin (TTM) Profitability N/A 0.0% Higher Margin PFSA
Net Profit Margin Profitability N/A 0.0% Higher Margin PFSA
Return on Equity (ROE) Capital Efficiency N/A 0.0% Higher ROE PFSA
52-Week Range Position Momentum 1% ($0โ€“$10) 1% ($0โ€“$28) Stronger Trend Tie
Beta / 30D Volatility Risk Regime -8.45ฮฒ ยท 672% Vol -9.00ฮฒ ยท 92% Vol Lower Realized Risk PFSA
Unified Institutional Score Composite Signal 47.5 / 100 (HOLD) 48.7 / 100 (HOLD) Higher Composite PFSA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full LABT vs PFSA Buy Guide
LABT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live LABT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PFSA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PFSA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither LABT nor PFSA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.